SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AtheroGenics, Inc.{AGIX}-nasdaq
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
332 21 0 AGIX
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
257<i>I don’t get your point about “someone else’s” patent not being subject Clarksterh-3/31/2007
256<i>The three years I tacked on were a rough (and conservative) estimate ofDewDiligence_on_SI-3/31/2007
255Correction to: <i> Liver failures are expected to be related to number ofClarksterh-3/31/2007
254FDA draft of concept paper on liver adverse events: fda.gov Bottom line: a) LClarksterh-3/31/2007
253<i>1) The Hatch-Waxman marketing-exclusivity period, which is not a patentClarksterh-3/31/2007
252<i>The statutory extension of a drug patent for a fraction of the time thaClarksterh-3/31/2007
251Patent extensions do not work like that! It sounds like you are confusing two reDewDiligence_on_SI-3/31/2007
250<i>My guess is that AZN will walk not because of safety or possible effectClarksterh-3/30/2007
249Here is your chance to see the stock in the 1s. My guess is that AZN will walk kenhott-3/30/2007
248forbes: AtheroGenics: Promise And Peril Matthew Herper, 03.27.07, 1:51 PM ET Amopgcw-3/30/2007
247Atherogenics Is Feeling the Squeeze By Adam Feuerstein Senior Writer 3/28/2007Doc Bones-3/29/2007
246I've compiled a pretty good chain of commentary on ARISE over on IHUB BiotecClarksterh-3/27/2007
245AtheroGenics Announces ARISE Phase III Clinical Study Results at the American Cosim1-3/27/2007
244AtheroGenics Schedules Conference Call and Webcast to Discuss ARISE Phase III Clsim1-3/27/2007
243<reply> aubdz. Be careful and good luck.kenhott-3/26/2007
242Forbes: Strange Days For AtheroGenics Matthew Herper, 03.19.07, 10:15 AM ET Bymopgcw-3/25/2007
241AGIX bounced some 13% yesterday and it looks like will again today due to this idos-3/22/2007
240P&G might be interested in a partnership!keokalani'nui-3/19/2007
239Well, I WAS long but someone bid the stock up in the first 1/2 hour and I was takenhott-3/19/2007
238Strange Days For AtheroGenics Matthew Herper [Forbes], 03.19.07, 10:15 AM ET Insim1-3/19/2007
237I actually bought some pre-market. Idea is a play on the upcoming meeting (editkenhott-3/19/2007
236AGIX reported meeting the secondary endpoint of "hard events." This eRudy Saucillo-3/19/2007
235I am surprised this turkey is holding above $1 given cash levels vs. debt. JonRobohogs-3/19/2007
234AtheroGenics Reports ARISE Trial Results for AGI-1067 Monday March 19, 6:30 am Ekenhott-3/19/2007
233AtheroGenics Announces Conference Call to Provide Business Update Monday March 1kenhott-3/19/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News